glutathione pathway to triple negative cancer The crosstalk between metabolism and non-coding RNAs in progression and treatment resistance GPX4 in triple-negative breast cancer:
GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect Metabolic reprogramming in triple negative breast cancer PMC Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect
Pay in 4 interest-free payments of $6.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



